Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $527.07 · Expires 2033-07-22 | Direct | 2,380 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 2,380 · Balance 2,380 F1: Annual non-employee director award. F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. |
| Common StockSEC Table I · non-derivative | Direct | 4,190 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,190 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual non-employee director award.
F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 13, 2023 Filed Jul 17, 2023 10:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 4,560 | $0.00 Strike: $229.81 | $0.00 |
DisclosureSEC source: 0001415889-23-011154 · form4-07172023_060715.xml · derivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,560 Underlying: Common Stock · 4,560 shares Expires 2033-07-13 F1 · shares: Annual non-employee director award. F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| July 07, 2023 Filed Jul 7, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010945 · form4-07072023_040701.xml · derivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 07, 2023 Filed Jul 7, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010945 · form4-07072023_040701.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| January 03, 2023 Filed Jan 3, 2023 22:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 1,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-23-000085 · form4-01032023_100101.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 03, 2023 Filed Jan 3, 2023 22:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $276.26 | $276,260.00 |
DisclosureSEC source: 0001415889-23-000085 · form4-01032023_100101.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| January 03, 2023 Filed Jan 3, 2023 22:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,000 | $175.43 | $175,430.00 |
DisclosureSEC source: 0001415889-23-000085 · form4-01032023_100101.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 03, 2022 Filed Nov 3, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,500 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-22-011052 · form4-11032022_041101.xml · derivative · entry 9 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 2,500 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 03, 2022 Filed Nov 3, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,500 | $260.00 | $650,000.00 |
DisclosureSEC source: 0001415889-22-011052 · form4-11032022_041101.xml · nonDerivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 03, 2022 Filed Nov 3, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,500 | $175.43 | $438,575.00 |
DisclosureSEC source: 0001415889-22-011052 · form4-11032022_041101.xml · nonDerivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,500 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-22-011052 · form4-11032022_041101.xml · derivative · entry 8 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Underlying: Common Stock · 2,500 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,500 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-22-011052 · form4-11032022_041101.xml · derivative · entry 7 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 2,500 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,500 | $250.01 | $625,024.25 |
DisclosureSEC source: 0001415889-22-011052 · form4-11032022_041101.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $250.00 to $250.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,500 | $175.43 | $438,575.00 |
DisclosureSEC source: 0001415889-22-011052 · form4-11032022_041101.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,500 | $240.00 | $600,000.00 |
DisclosureSEC source: 0001415889-22-011052 · form4-11032022_041101.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,500 | $175.43 | $438,575.00 |
DisclosureSEC source: 0001415889-22-011052 · form4-11032022_041101.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 3,500 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-22-009057 · form4-08252022_040801.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Common Stock · 3,500 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 3,500 | $224.96 | $787,359.65 |
DisclosureSEC source: 0001415889-22-009057 · form4-08252022_040801.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 F1 · price: This transaction was executed in multiple trades at prices ranging from $224.938 to $225.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,500 | $175.43 | $614,005.00 |
DisclosureSEC source: 0001415889-22-009057 · form4-08252022_040801.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 21:49 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Units · Derivative | 2,160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007607 · form4-07082022_020719.xml · derivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 21:49 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007607 · form4-07082022_020719.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 21:49 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007607 · form4-07082022_020719.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 5,000 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001415889-22-007024 · form4-06282022_010609.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 5,000 | $236.79 | $1,183,950.00 |
DisclosureSEC source: 0001415889-22-007024 · form4-06282022_010609.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $76.36 | $381,800.00 |
DisclosureSEC source: 0001415889-22-007024 · form4-06282022_010609.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005904 · form4-05312022_040507.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675 Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:46 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 5,000 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001415889-22-005700 · form4-05262022_010539.xml · derivative · entry 8 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:46 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 200 | $227.44 | $45,487.50 |
DisclosureSEC source: 0001415889-22-005700 · form4-05262022_010539.xml · nonDerivative · entry 7 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 F6 · price: This transaction was executed in multiple trades at prices ranging from $227.4125 to $227.4625. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:46 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 350 | $226.72 | $79,353.02 |
DisclosureSEC source: 0001415889-22-005700 · form4-05262022_010539.xml · nonDerivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950 F5 · price: This transaction was executed in multiple trades at prices ranging from $226.33 to $226.925. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:46 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 167 | $226.06 | $37,751.60 |
DisclosureSEC source: 0001415889-22-005700 · form4-05262022_010539.xml · nonDerivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F4 · price: This transaction was executed in multiple trades at prices ranging from $225.30 to $226.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:46 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 983 | $224.10 | $220,290.50 |
DisclosureSEC source: 0001415889-22-005700 · form4-05262022_010539.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,467 F3 · price: This transaction was executed in multiple trades at prices ranging from $223.83 to $224.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:46 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,600 | $222.96 | $579,683.52 |
DisclosureSEC source: 0001415889-22-005700 · form4-05262022_010539.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,450 F2 · price: This transaction was executed in multiple trades at prices ranging from $222.71 to $223.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:46 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 700 | $221.65 | $155,156.61 |
DisclosureSEC source: 0001415889-22-005700 · form4-05262022_010539.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,050 F1 · price: This transaction was executed in multiple trades at prices ranging from $221.56 to $222.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:46 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $76.36 | $381,800.00 |
DisclosureSEC source: 0001415889-22-005700 · form4-05262022_010539.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,610 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001127602-21-023274 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 2,610 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,610 | $210.00 | $548,100.00 |
DisclosureSEC source: 0001127602-21-023274 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| August 06, 2021 Filed Aug 6, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,610 | $76.36 | $199,299.60 |
DisclosureSEC source: 0001127602-21-023274 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,360 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 20:49 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Units · Derivative | 2,160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-021758 · form4.xml · derivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,160 Underlying: Common Stock · 2,160 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018328 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 21:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 1,500 | $0.00 Strike: $88.03 | $0.00 |
DisclosureSEC source: 0001127602-21-001975 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2024-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 21:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 1,500 | $172.82 | $259,230.00 |
DisclosureSEC source: 0001127602-21-001975 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 15, 2021 Filed Jan 19, 2021 21:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,500 | $88.03 | $132,045.00 |
DisclosureSEC source: 0001127602-21-001975 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:38 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 1,500 | $0.00 Strike: $88.03 | $0.00 |
DisclosureSEC source: 0001127602-21-001272 · form4.xml · derivative · entry 6 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2024-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:38 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 1,500 | $167.05 | $250,575.00 |
DisclosureSEC source: 0001127602-21-001272 · form4.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 21:38 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,500 | $88.03 | $132,045.00 |
DisclosureSEC source: 0001127602-21-001272 · form4.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:38 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 1,500 | $0.00 Strike: $88.03 | $0.00 |
DisclosureSEC source: 0001127602-21-001272 · form4.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,500 shares Expires 2024-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:38 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 1,500 | $163.51 | $245,265.00 |
DisclosureSEC source: 0001127602-21-001272 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 06, 2021 Filed Jan 8, 2021 21:38 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,500 | $88.03 | $132,045.00 |
DisclosureSEC source: 0001127602-21-001272 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 1,500 | $0.00 Strike: $88.03 | $0.00 |
DisclosureSEC source: 0001127602-21-000989 · form4.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 1,500 shares Expires 2024-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 1,500 | $156.77 | $235,155.00 |
DisclosureSEC source: 0001127602-21-000989 · form4.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,500 | $88.03 | $132,045.00 |
DisclosureSEC source: 0001127602-21-000989 · form4.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.